发明名称 Humanised antibodies.
摘要 CDR grafted antibody is claimed having one chain derived from a first (acceptor) antibody and (pref. 2) CDR(s) derived from a second (donor) antibody. Residue(s) pref. residue 35 in the CDR grafted chain has been altered so it corresp. to the equiv. residue in the antibody. The CDR chains are pref. derived from a human lgG chain. The heavy chain may be derived from the human NEW M or EU or pref. KOL chain. The light chain is pref. derived from the human REl light chain. The CDR grafted antibody has an affinity for the CD4 antigen of 10power5 - 10power12 M-1 pref. 10power8. Affinity is similar to that of OKT4A. CDR(s) may be derived from a mammalian (murine) antibody. Prodn. of the antibody is claimed by recombinant DNA technology.
申请公布号 EP0626390(A1) 申请公布日期 1994.11.30
申请号 EP19940202090 申请日期 1990.12.21
申请人 CELLTECH LIMITED 发明人 ADAIR, JOHN ROBERT;ATHWAL, DILJEET SINGH;EMTAGE, JOHN SPENCER
分类号 A61K39/395;A61K;A61K38/00;A61K49/00;A61P37/00;C07K14/435;C07K14/52;C07K14/525;C07K14/725;C07K16/00;C07K16/18;C07K16/24;C07K16/28;C07K16/42;C07K16/46;C07K19/00;C12N;C12N5/10;C12N15/09;C12N15/13;C12P21/00;C12P21/02;C12P21/08;C12Q;C12R1/91;G01N33/53;G01N33/577 主分类号 A61K39/395
代理机构 代理人
主权项
地址